Home >> Health >> Pharmacy >> Drugs and Medications >> N >> Naratriptan




Naratriptan (AmergeĀ®) occurs as triptan drug developed by Glaxo Wellcome Inc. utilized for the professional assistance of migraine headaches. Naratriptan is available inside Two.5mg tablets. These are the selective Five-hydroxytryptamine1 receptor subtype agonist. NaratriptaNorth hydrochloride is chemically intended when N-methyl-Three-( One-methyl-Four-piperidinyl)-1H-indole-Five-ethanesulfonamide.

Occasionally side results of the drug include vision changes, tingling sensations, weariness or even weakness, upset belly, lightheadedness, & warm/cold temperature sensations. A FDA approved Amerge on February 11, 1998.

Amerge
Product information from Glaxo Wellcome, in Portable Document Format (PDF). (naratriptan hydrochloride)

DrugDigest: Naratriptan ( Amerge )
Information on dosage, usage, side effects, interactions, and drug comparisons including generics when available.

Amerge
Full prescribing information from RxList.

Amerge Consumer Information - FDA
Consumer FAQ in html format with a link to approved labeling in pdf format.






© 2005 GeneralAnswers.org